Time-to-Treatment Delays and Their Prognostic Implications in Pharyngeal Cancer-An Exploratory Analysis in Western Romania.
Autor: | Kiș AM; Faculty of Pharmacy, 'Victor Babeș' University of Medicine and Pharmacy, Eftimie Murgu Square No. 2, 300041 Timișoara, Romania.; Research Center for Pharmaco-Toxicological Evaluations, Faculty of Pharmacy, 'Victor Babeș' University of Medicine and Pharmacy, 300041 Timișoara, Romania., Buzatu R; Department of Dental Aesthetics, Faculty of Dental Medicine, 'Victor Babeș' University of Medicine and Pharmacy, 300041 Timișoara, Romania., Chisavu L; Department of Nephrology, 'Victor Babeș' University of Medicine and Pharmacy, 300041 Timișoara, Romania., Poenaru M; Department of ENT, 'Victor Babeș' University of Medicine and Pharmacy, 300041 Timișoara, Romania., Borza C; Department of Functional Sciences-Pathophysiology, 'Victor Babeș' University of Medicine and Pharmacy, 300041 Timișoara, Romania.; Centre for Translational Research and Systems Medicine, 'Victor Babeș' University of Medicine and Pharmacy, 300041 Timișoara, Romania., Iftode A; Faculty of Pharmacy, 'Victor Babeș' University of Medicine and Pharmacy, Eftimie Murgu Square No. 2, 300041 Timișoara, Romania.; Research Center for Pharmaco-Toxicological Evaluations, Faculty of Pharmacy, 'Victor Babeș' University of Medicine and Pharmacy, 300041 Timișoara, Romania., Sarau OS; Department of Hematology, 'Victor Babeș' University of Medicine and Pharmacy, 300041 Timișoara, Romania., Dehelean CA; Faculty of Pharmacy, 'Victor Babeș' University of Medicine and Pharmacy, Eftimie Murgu Square No. 2, 300041 Timișoara, Romania.; Research Center for Pharmaco-Toxicological Evaluations, Faculty of Pharmacy, 'Victor Babeș' University of Medicine and Pharmacy, 300041 Timișoara, Romania., Ardelean S; Department of Pharmaceutical Technology, Faculty of Pharmacy, 'Vasile Goldiș' Western University, 86 Liviu Rebreanu, 310045 Arad, Romania. |
---|---|
Jazyk: | angličtina |
Zdroj: | Clinics and practice [Clin Pract] 2024 Jun 29; Vol. 14 (4), pp. 1270-1284. Date of Electronic Publication: 2024 Jun 29. |
DOI: | 10.3390/clinpract14040103 |
Abstrakt: | Background: Diagnosis and treatment for pharyngeal cancer are decisive in determining prognosis. Diagnosis delays are frequent, representing a significant cause of avoidable mortality, and an important factor in subpar survival across the continuous HNC care delivery. Methods: The present study represents a retrospective analysis of medical records from Western Romania, which included 180 patients, to evaluate the impact of time-to-treatment delay on patients diagnosed with pharyngeal cancer. The data analyses were performed using the Kaplan-Meier method R (version 3.6.3) packages, including tidyverse, final-fit, mcgv, survival, stringdist, janitor, and Hmisc. Results: The mean days from diagnosis until the end of treatment were higher for the nasopharynx group. Cox regression analysis regarding diagnosis to treatment duration categories showed an increased risk mortality by 3.11 times (95%CI: 1.51-6.41, p = 0.0021) with a Harrell's C-index of 0.638 (95%CI: 0.552-0.723). The hypopharynx and oropharynx locations increased risk mortality by 4.59 (95%CI: 1.55-13.55) and 5.49 times (95%CI: 1.79-16.81) compared to the nasopharynx location. Conclusions: The findings of this study led to the conclusion that it seems there is a trend of mortality risk for oropharynx and hypopharynx cancers due to delays in the time to treatment over 70 days, standing as a basis for further research as there is an imperative need for prospective multicenter studies. |
Databáze: | MEDLINE |
Externí odkaz: | |
Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |